Mark Mirkin is a partner in the firm's Corporate Finance & Securities Section. His practice focuses on corporate and securities law, with an emphasis on entrepreneurship and emerging growth companies. Mr. Mirkin has represented clients in private placements and public offerings of equity, debt and convertible securities, venture capital financings, mergers, acquisitions, and divestitures. He has structured and formed hundreds of new companies, advising them with respect to the development of their business plans. He regularly negotiates and orchestrates seed and early stage investment capital financings for client companies including those in the life sciences and information technology industries. Mr. Mirkin has advocated for clients with securities regulators at the U.S. Securities and Exchange Commission and at numerous state Blue Sky commissions.

Education
Duke University School of Law, J.D.
Duke University, B.A., cum laude

Professional Affiliations


Publications
Author, "Reverse Mergers as a Means for Going Public," Triangle TechJournal, October 2006
Author, "Paying Finders for Raising Investment Capital," Triangle TechJournal, July 2005
Author, "TechLaw: Clinical Drug Trials," Triangle TechJournal, May 2004
Author, "Structuring Investments," Triangle TechJournal, February 2004
Author, "Gaining Capital in a Tight Economy," Business Leader, November 2003

Community Involvement
American Diabetes Association, Eastern North Carolina Division - Leadership Committee